Heartflow director awarded 16,075 stock options

Heartflow, Inc. director Casey M. Tansey reported a grant of stock options.

Rhea-AI Filing Summary

Heartflow, Inc. director Casey M. Tansey reported a grant of stock options. On the reported date, Tansey received options covering 16,075 shares of Common Stock at an exercise price of $32.05 per share. Following this grant, Tansey held 16,075 derivative securities directly.

The option will vest in full on the earlier of the day prior to Heartflow's 2027 annual meeting of shareholders and the first anniversary of the grant date, subject to continued service through that date. The options are scheduled to expire on June 16, 2036 if not exercised.

Insider Trade Summary

Grant/Award: 16,075 shares

Grant/Award 1 txn

Insider Tansey Casey M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	16,075	$32.05	$515K

Holdings After Transaction: Stock Option — 16,075 contracts (Direct)

Footnotes (1)

1. F1. The option will vest in full on the earlier of the day prior to Heartflow's annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service through such date.

Key Figures

Stock options granted: 16,075 options Exercise price: $32.05 per share Options held after grant: 16,075 derivative securities +2 more

5 metrics

Stock options granted 16,075 options Grant to director Casey M. Tansey on reported date

Exercise price $32.05 per share Exercise price for granted stock options

Options held after grant 16,075 derivative securities Total derivative securities following the transaction

Expiration date June 16, 2036 Expiration of stock options if not exercised

Underlying shares 16,075 shares of Common Stock Shares underlying the stock options

Key Terms

Stock Option, Common Stock, grant/award acquisition, annual meeting of shareholders

4 terms

Stock Option financial

"security_title: "Stock Option""

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

grant/award acquisition financial

"transaction_action: "grant/award acquisition""

annual meeting of shareholders financial

"earlier of the day prior to Heartflow's annual meeting of shareholders in 2027"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Heartflow (HTFL) director Casey M. Tansey report on this Form 4?

Director Casey M. Tansey reported receiving a grant of stock options for 16,075 shares of Heartflow Common Stock. These options are compensation-related, not an open-market purchase, and give the right to buy shares at a fixed exercise price of $32.05 per share.

How many Heartflow (HTFL) stock options were granted to Casey M. Tansey?

The filing shows a grant of 16,075 stock options to director Casey M. Tansey. Each option relates to one share of Heartflow Common Stock, creating potential future ownership if exercised at the stated exercise price, subject to vesting and continued service conditions described in the footnote.

What is the exercise price of Casey M. Tansey’s Heartflow (HTFL) stock options?

The stock options granted to Casey M. Tansey have an exercise price of $32.05 per share. This means Tansey can purchase Heartflow Common Stock at $32.05 if the options vest and are later exercised before their stated expiration date in June 2036.

When do Casey M. Tansey’s Heartflow (HTFL) stock options vest?

The options will vest in full on the earlier of the day before Heartflow’s 2027 annual shareholder meeting and the first anniversary of the grant date. Vesting is conditioned on Tansey’s continued service through that vesting date, as described in the Form 4 footnote.

When do the reported Heartflow (HTFL) stock options expire?

The stock options reported for Casey M. Tansey are scheduled to expire on June 16, 2036. If they are not exercised by that expiration date, they lapse and no longer provide the right to purchase Heartflow Common Stock at the $32.05 exercise price.

Is Casey M. Tansey buying or selling Heartflow (HTFL) shares in this Form 4?

This Form 4 reports an acquisition of stock options as a grant or award, not a market trade. There are no open-market buys or sells disclosed. It reflects compensation in the form of options rather than immediate share purchases or sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 05:26 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tansey Casey M

(Last) (First) (Middle)

C/O HEARTFLOW, INC.

135 MAIN STREET, SUITE 1000

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Heartflow, Inc. [ HTFL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$32.05	06/16/2026		A		16,075		(1)	06/16/2036	Common Stock	16,075	$32.05	16,075	D

Explanation of Responses:

1. The option will vest in full on the earlier of the day prior to Heartflow's annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service through such date.

	/s/ Nga Van, by power of attorney	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)